TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/13/24 17:38 | 2/9/24 | EYPT | Eyepoint Pharmaceuticals, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Elston George | MA | O | CFO | M.d | 0 | 0.00 | 0 | 11 | 33 | 44 | D | ||||||||||||||
1/9/24 21:04 | 1/6/24 | EYPT | Eyepoint Pharmaceuticals, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Elston George | MA | O | CFO | M.d | 0 | 0.00 | 0 | 15 | 76 | 35 | D | ||||||||||||||
2/13/23 16:58 | 2/9/23 | EYPT | Eyepoint Pharmaceuticals, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Elston George | MA | O | CFO | M.d | 0 | 0.00 | 0 | 11 | 88 | 23 | D | ||||||||||||||
2/11/22 16:41 | 2/9/22 | EYPT | Eyepoint Pharmaceuticals, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Elston George | MA | O | CFO | M.d | 0 | 0.00 | 0 | 5 | 107 | 10 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |